Triple-negative breast cancer (TNBC) accounts for approximately 15% of all breast cancer cases and is defined by the absence of estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2) [1]. Here, ERBB2 is linked to triple-negative breast carcinoma.